Correction: miR146a-mediated targeting of FANCM during inflammation compromises genome integrity

Oncotarget. 2020 May 26;11(21):2024-2025. doi: 10.18632/oncotarget.27481.

Devakumar Sundaravinayagam^#^{1

2}, Hye Rim Kim^#^{1

3}, TingTing Wu^#^{1

3}, Hyun Hee Kim^{1

3}, Hyun-Seo Lee^{1

2}, Semo Jun^{1

2}, Jeong-Heon Cha⁴, Younghoon Kee⁵, Ho Jin You^{1

2}, Jung-Hee Lee^{1

3}

¹ Laboratory of Genomic Instability and Cancer Therapeutics, Cancer Mutation Research Center, Chosun University School of Medicine, Gwangju, Republic of Korea.
² Department of Pharmacology, Chosun University School of Medicine, Gwangju, Republic of Korea.
³ Department of Cellular and Molecular Medicine, Chosun University School of Medicine, Gwangju, Republic of Korea.
⁴ Department of Oral Biology, Department of Applied Life Science, The Graduate School, Yonsei University College of Dentistry, Seoul, Republic of Korea.
⁵ Department of Cell Biology, Microbiology, and Molecular Biology, College of Arts and Sciences, University of South Florida, Tampa, Florida, United States of America.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.10275.].